March 13, 2018 / 11:50 AM / 3 months ago

BRIEF-Intra-Cellular Therapies Announces Positive Pre-NDA Meeting With FDA For Schizophrenia Treatment

March 13 (Reuters) - Intra-Cellular Therapies Inc:

* INTRA-CELLULAR THERAPIES ANNOUNCES POSITIVE PRE-NDA MEETING WITH FDA FOR LUMATEPERONE FOR THE TREATMENT OF SCHIZOPHRENIA

* INTRA-CELLULAR THERAPIES INC - ‍FDA AGREED ON PROPOSED CONTENT AND TIMING OF A ROLLING NDA SUBMISSION​

* INTRA-CELLULAR THERAPIES INC - ‍PLANS TO COMPLETE ITS NDA SUBMISSION BY MID-2018.​

* INTRA-CELLULAR THERAPIES - ‍HAD POSITIVE PRE-NDA MEETING WITH FDA REGARDING LUMATEPERONE FOR TREATMENT OF SCHIZOPHRENIA​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below